blog
2025-01-25 12:00:00
Confident business result for first fiscal year 2024
While preliminary unaudited results indicate a slight net loss for the year, the company secured a solid revenue base and anticipates significant backlog in its consulting division.
The firm’s obstetrics and gynecology research and development is also progressing well, exceeding initial projections and is on track to move into the next phase ahead of schedule, barring any unforeseen circumstances.
From February onwards, we are heading for next R&D phase working with several global partners in order to make the functional mockups.
We are expecting to set up the headquarters room as lab in February.
Thanks for all the supporters who sponsor this small startup company.
Dai, CEO
